StemCells stemcellsinc.com

StemCells (NASDAQ: STEM) is engaged in clinical development of its proprietary HuCNS-SC (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CNS).

StemCells (NASDAQ: STEM) is engaged in clinical development of its proprietary HuCNS-SC (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CNS).

See All Exits Recent Exits

Phone: 650-670-2282

Fax:

39899 Balentine Drive
Ste 200
Newark, 94560
California, United States

StemCells - Investments & Acquisitions

Show Real Data StemCells Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-08-16Microbot MedicalReverse Merger
See all 1 investments